Diphtheria Pipeline Products and Comparative Analysis with Company Profiles Research Report Available at RnRMarketResearch.com



Diphtheria Pipeline Review H1 2015

The report Neutropenia – Pipeline Review, H1 2015 provides comparative analysis on the therapeutic development for Neutropenia. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report with TOC is available at http://www.rnrmarketresearch.com/diphtheria-pipeline-review-h1-2015-market-report.html .

The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this report are:-


Beijing Minhai Biotechnology Co., Ltd
Biological E. Limited
Daiichi Sankyo Company, Limited
GlaxoSmithKline Plc
Green Cross Corporation
Indian Immunologicals Limited
LG Life Sciences, Ltd.
Panacea Biotec Limited
Prometheon Pharma, LLC
Sanofi
Sanofi Pasteur SA
Serum Institute of India Limited
Sinovac Biotech Ltd.
Zydus Cadila Healthcare Limited

Order a purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=395210 . (This is a premium report priced at US$ 2000 for a single user License.)

Drug profiles mentioned in this reports are:-

(diphtheria + tetanus + pertussis) vaccine
diphtheria + pertussis (acellular) + tetanus vaccine
diphtheria + pertussis + tetanus + hepatitis B + haemophilus influenza [serotype B] vaccine
diphtheria + pertussis + tetanus vaccine
diphtheria + tetanus + pertussis (acellular) + haemophilus influenza [serotype B] + polio [sabin] vaccine
diphtheria + tetanus + pertussis (acellular) vaccine
diphtheria + tetanus + pertussis (whole cell) + haemophilus influenzae [serotype B] + polio (pentavalent) vaccine
diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B] + polio (hexavalent) vaccine
diphtheria + tetanus + pertussis (whole-cell) + haemophilus influenzae [serotype B] vaccine
diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] (pentavalent) vaccine
diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] vaccine
diphtheria + tetanus + pertussis (whole-cell) + poliomyelitis + haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] (7-valent) vaccine
diphtheria + tetanus + pertussis (whole-cell) vaccine
diphtheria + tetanus vaccine
diphtheria + tetanus+ pertussis (whole cell) vaccine
diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + haemophilus influenzae [type B] (pentavalent) vaccin
diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + poliomyelitis + haemophilus influenzae [type B] (hexavalent) vaccine
diphtheria vaccine
GC-1107
GC-3111A
PR-5I
VN-0103

Scope of this report:

The report provides a snapshot of the global therapeutic landscape of Diphtheria. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Diphtheria and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects. A review of the Diphtheria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage is based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Table of Contents:-

List of Tables
List of Figures
Diphtheria Overview
Therapeutics Development
Pipeline Products for Diphtheria – Comparative Analysis
Diphtheria – Therapeutics under Development by Companies
Diphtheria – Therapeutics under Investigation by Universities/Institutes
Diphtheria – Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Drug Profiles
Featured News & Press Releases

Ritesh Tiwari

TX, Dallas North – Dominion Plaza

17304, Preston Road,

Suite 800, Dallas 75252

Tel: +1-888-391-5441

sales(at)rnrmarketresearch(dot)com







This entry was posted in Biotech and tagged , , , , , , , , , , , . Bookmark the permalink.